Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $412 | $721 | $760 | $683 |
| Short-Term Investments | $357 | $97 | $97 | $94 |
| Receivables | $332 | $326 | $311 | $297 |
| Inventory | $170 | $174 | $149 | $158 |
| Other Curr. Assets | $59 | $49 | $36 | $77 |
| Total Curr. Assets | $1,329 | $1,368 | $1,352 | $1,308 |
| Property Plant & Equip (Net) | $405 | $405 | $397 | $385 |
| Goodwill | $8 | $9 | $9 | $9 |
| Intangibles | $30 | $32 | $31 | $32 |
| Long-Term Investments | $429 | $417 | $400 | $417 |
| Tax Assets | $0 | $0 | $13 | $0 |
| Other NC Assets | $88 | $90 | $75 | $79 |
| Total NC Assets | $960 | $953 | $924 | $921 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,289 | $2,321 | $2,277 | $2,229 |
| Liabilities | – | – | – | – |
| Payables | $115 | $109 | $94 | $125 |
| Short-Term Debt | $6 | $7 | $10 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $19 | $0 |
| Other Curr. Liab. | $196 | $190 | $152 | $211 |
| Total Curr. Liab. | $343 | $319 | $313 | $370 |
| LT Debt | $10 | $12 | $11 | $12 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $29 | $0 |
| Other NC Liab. | $107 | $99 | $65 | $101 |
| Total NC Liab. | $116 | $111 | $109 | $113 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $1,097 | $0 |
| Total Liabilities | $460 | $430 | $422 | $483 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $58 | $59 | $56 | $56 |
| Retained Earnings | $1,517 | $1,782 | $1,711 | $1,663 |
| AOCI | $307 | $322 | $347 | $290 |
| Other Equity | $23 | $23 | $22 | $23 |
| Total Equity | $1,811 | $1,874 | $1,837 | $1,730 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $18 | $18 | $17 | $16 |
| Total Liab. & Tot. Equity | $2,289 | $2,321 | $2,277 | $2,229 |
| Net Debt | -$395 | -$703 | -$739 | -$663 |